Characteristic | No. (%) |
---|---|
Sex | |
Male | 161 (61.5) |
Female | 101(38.5) |
Age | |
Median | 57 |
Range | (19, 87) |
Smoke | |
Yes | 73 (27.9) |
No | 189 (72.1) |
Primary tumour site | |
Nasal cavity | 139 (53) |
Paranasal sinus | 22 (8.4) |
Oral cavity | 67 (25.6) |
Others | 34 (13) |
Tumor classification | |
T3 | 114 (43.5) |
T4a | 136 (51.9) |
T4b | 12 (4.6) |
Node classification | |
N0 | 195(74.4) |
N1 | 67 (25.6) |
Overall stage | |
III | 85 (32.4) |
IVa | 165 (63) |
IVb | 12 (4.6) |
Reoperation | |
Yes | 107 (43.5) |
No | 139 (56.5) |
Irradiation technique | |
2DRT | 22 (18.9) |
IMRT | 84 (81.3) |
Surgery | |
Yes | 246 (93.9) |
No | 16 (6.1) |
Radiotherapy | |
Yes | 106 (40.5) |
No | 156 (59.5) |
Chemotherapy | |
Yes | 149 (56.9) |
No | 113 (43.1) |
Immunologic/targeted therapy | |
Yes | 69 (26.3) |
No | 193 (73.7) |
Treatment modality | |
Surgery alone | 83 (33.7) |
Surgery + RT | 26 (10.6) |
Surgery + CT | 61 (24.8) |
Surgery + RT + CT | 76 (30.9) |